At-Home Diagnostics Solutions for Chlamydia and Gonorrhea
- PMID: 38683579
- PMCID: PMC11132916
- DOI: 10.1001/jama.2024.5574
At-Home Diagnostics Solutions for Chlamydia and Gonorrhea
Plain language summary
This Viewpoint discusses the US Food and Drug Administration’s authorization of marketing an at-home testing system for chlamydia and gonorrhea as a good first step in boosting access to screening and treatment and in reducing infection rates.
References
-
- Food and Drug Administration (FDA). FDA Grants Marketing Authorization of First Test for Chlamydia and Gonorrhea with at-home Sample Collection. Updated November/15/2023. Accessed 12/20, 2023. https://www.fda.gov/news-events/press-announcements/fda-grants-marketing...
-
- World Health Organization. WHO Consolidated Guideline on Self-Care Interventions for Health: Sexual and Reproductive Health and Rights. 2019. https://www.ncbi.nlm.nih.gov/pubmed/31334932 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical